Stay updated on Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe page header/footer software revision indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a version change in the ClinicalTrials.gov interface/system.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedThe Record History page shows a new revision label (v3.5.0) and removes the previous revision (v3.4.3), indicating a system version update rather than changes to study content.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page header.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; the study record content and history listing appear unchanged.SummaryDifference0.0%

- Check86 days agoChange DetectedThe revision history now shows a new latest revision, v3.4.1, and removes the previous revision, v3.4.0.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page history now lists revision v3.4.1 and removes v3.4.0, indicating a minor version update to the history page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.